Mccarter Private Wealth Services LLC Trims Holdings in UnitedHealth Group Incorporated $UNH

Mccarter Private Wealth Services LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 36.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,375 shares of the healthcare conglomerate’s stock after selling 1,904 shares during the quarter. UnitedHealth Group comprises approximately 1.2% of Mccarter Private Wealth Services LLC’s holdings, making the stock its 27th biggest position. Mccarter Private Wealth Services LLC’s holdings in UnitedHealth Group were worth $1,768,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. Bayforest Capital Ltd boosted its stake in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its stake in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the period. Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group during the fourth quarter worth $41,000. Finally, Copia Wealth Management bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $42,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $303.4150 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm has a market capitalization of $274.79 billion, a price-to-earnings ratio of 13.15, a PEG ratio of 1.93 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock’s 50-day simple moving average is $288.51 and its 200-day simple moving average is $391.21.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 EPS. UnitedHealth Group’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. Wolfe Research decreased their target price on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research report on Tuesday, May 20th. Wall Street Zen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. TD Securities reiterated a “hold” rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Bank of America lifted their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a report on Monday. Finally, JPMorgan Chase & Co. decreased their price objective on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $365.38.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.